211 related articles for article (PubMed ID: 21969570)
21. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
AbdElazeem MA; El-Sayed M
Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
[TBL] [Abstract][Full Text] [Related]
22. Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation.
Risques RA; Lai LA; Himmetoglu C; Ebaee A; Li L; Feng Z; Bronner MP; Al-Lahham B; Kowdley KV; Lindor KD; Rabinovitch PS; Brentnall TA
Cancer Res; 2011 Mar; 71(5):1669-79. PubMed ID: 21363920
[TBL] [Abstract][Full Text] [Related]
23. Colonic Mucosal Transcriptomic Changes in Patients with Long-Duration Ulcerative Colitis Revealed Colitis-Associated Cancer Pathways.
Low END; Mokhtar NM; Wong Z; Raja Ali RA
J Crohns Colitis; 2019 May; 13(6):755-763. PubMed ID: 30954025
[TBL] [Abstract][Full Text] [Related]
24. Evolutionary history of human colitis-associated colorectal cancer.
Baker AM; Cross W; Curtius K; Al Bakir I; Choi CR; Davis HL; Temko D; Biswas S; Martinez P; Williams MJ; Lindsay JO; Feakins R; Vega R; Hayes SJ; Tomlinson IPM; McDonald SAC; Moorghen M; Silver A; East JE; Wright NA; Wang LM; Rodriguez-Justo M; Jansen M; Hart AL; Leedham SJ; Graham TA
Gut; 2019 Jun; 68(6):985-995. PubMed ID: 29991641
[TBL] [Abstract][Full Text] [Related]
25. Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes.
Karagiannides I; Kokkotou E; Tansky M; Tchkonia T; Giorgadze N; O'Brien M; Leeman SE; Kirkland JL; Pothoulakis C
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):5207-12. PubMed ID: 16549770
[TBL] [Abstract][Full Text] [Related]
26. Molecular profiling of ulcerative colitis-associated neoplastic progression.
Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
[TBL] [Abstract][Full Text] [Related]
27. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
Sato A; MacHinami R
Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells.
Goode T; O'Connell J; Ho WZ; O'Sullivan GC; Collins JK; Douglas SD; Shanahan F
Clin Diagn Lab Immunol; 2000 May; 7(3):371-6. PubMed ID: 10799448
[TBL] [Abstract][Full Text] [Related]
29. Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma.
Fogt F; Vortmeyer AO; Goldman H; Giordano TJ; Merino MJ; Zhuang Z
Hum Pathol; 1998 Feb; 29(2):131-6. PubMed ID: 9490271
[TBL] [Abstract][Full Text] [Related]
30. The neurokinin-1 receptor antagonist LY306,740 blocks nociception-induced increases in dorsal horn neurokinin-1 receptor gene expression.
McCarson KE; Krause JE
Mol Pharmacol; 1996 Nov; 50(5):1189-99. PubMed ID: 8913350
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the Changes in Mitochondrial Gene Polymorphism in Ulcerative Colitis and the Etiology of Ulcerative Colitis-associated Colorectal Cancer.
Tanaka T; Kobunai T; Yamamoto Y; Murono K; Emoto S; Hiyoshi M; Kaneko M; Sasaki K; Shuno Y; Nishikawa T; Hata K; Kawai K; Nozawa H; Ishihara S
Anticancer Res; 2020 Jan; 40(1):101-107. PubMed ID: 31892558
[TBL] [Abstract][Full Text] [Related]
32. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
Löfberg R
Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
[TBL] [Abstract][Full Text] [Related]
33. Shift from pStat6 to pStat3 predominance is associated with inflammatory bowel disease-associated dysplasia.
Wick EC; LeBlanc RE; Ortega G; Robinson C; Platz E; Pardoll DM; Iacobuzio-Donahue C; Sears CL
Inflamm Bowel Dis; 2012 Jul; 18(7):1267-74. PubMed ID: 22021169
[TBL] [Abstract][Full Text] [Related]
34. Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation.
Lai JP; Ho WZ; Kilpatrick LE; Wang X; Tuluc F; Korchak HM; Douglas SD
Proc Natl Acad Sci U S A; 2006 May; 103(20):7771-6. PubMed ID: 16675550
[TBL] [Abstract][Full Text] [Related]
35. Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease.
Michalski CW; Autschbach F; Selvaggi F; Shi X; Di Mola FF; Roggo A; Müller MW; Di Sebastiano P; Büchler MW; Giese T; Friess H
Am J Surg; 2007 Apr; 193(4):476-81. PubMed ID: 17368292
[TBL] [Abstract][Full Text] [Related]
36. IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer.
Li Y; Deuring J; Peppelenbosch MP; Kuipers EJ; de Haar C; van der Woude CJ
Carcinogenesis; 2012 Oct; 33(10):1889-96. PubMed ID: 22739025
[TBL] [Abstract][Full Text] [Related]
37. Sensory neuron and substance P involvement in symptoms of a zymosan-induced rat model of acute bowel inflammation.
Landau AM; Yashpal K; Cahill CM; St Louis M; Ribeiro-da-Silva A; Henry JL
Neuroscience; 2007 Mar; 145(2):699-707. PubMed ID: 17257769
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of DNA methyltransferase-1 in non-neoplastic epithelium helps predict colorectal neoplasia risk in ulcerative colitis.
Fujii S; Katake Y; Tanaka H
Digestion; 2010; 82(3):179-86. PubMed ID: 20588031
[TBL] [Abstract][Full Text] [Related]
39. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
Vigna SR
Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
[TBL] [Abstract][Full Text] [Related]
40. Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis.
Wang YD; Yan PY
World J Gastroenterol; 2006 Oct; 12(37):6050-3. PubMed ID: 17009408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
